Inhibrx Inc (INBX)
34.31
-0.39
(-1.12%)
USD |
NASDAQ |
May 10, 16:00
34.31
0.00 (0.00%)
After-Hours: 20:00
Inhibrx Shareholders Equity (Quarterly): 43.50M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 43.50M |
| September 30, 2023 | 129.60M |
| June 30, 2023 | -24.81M |
| March 31, 2023 | 15.13M |
| December 31, 2022 | 58.06M |
| September 30, 2022 | -35.05M |
| June 30, 2022 | -4.922M |
| March 31, 2022 | 27.35M |
| December 31, 2021 | 52.38M |
| Date | Value |
|---|---|
| September 30, 2021 | 28.20M |
| June 30, 2021 | 44.32M |
| March 31, 2021 | 60.59M |
| December 31, 2020 | 75.47M |
| September 30, 2020 | 91.73M |
| June 30, 2020 | -19.24M |
| December 31, 2019 | -93.57M |
| June 30, 2019 | -59.24M |
| March 31, 2019 | -60.58M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-93.57M
Minimum
Dec 2019
129.60M
Maximum
Sep 2023
22.91M
Average
28.20M
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
| Axonics Inc | 627.10M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -11.38M |
| iBio Inc | 9.197M |
| Theriva Biologics Inc | 39.70M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 307.89M |
| Total Liabilities (Quarterly) | 264.39M |
| Debt to Equity Ratio | 4.758 |
| Current Ratio | 5.245 |
| Net Debt Paydown Yield | -0.40% |